SBI HEALTHCARE OPPORTUNITIES FUND
SBI Mutual Fund · Sectoral / Thematic · Regular Growth · AMFI 102823 · ISIN INF200K01446
NAV₹544.341320 Nov 2026
3Y return+23.51%a year
5Y return+19.64%a year
Expense ratio1.97%₹6,067 Cr
Growth Score89.0★★★★★
Returns
| 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 7Y | 10Y | Since launch |
| Fund | +12.88% | +5.12% | +16.49% | +29.16% | +26.00% | +23.51% | +19.64% | +24.26% | +14.88% | +13.91% |
| NIFTY Healthcare TRI | +12.35% | +6.16% | +10.59% | +20.00% | +18.07% | +20.97% | +15.83% | — | — | — |
| Category middle | +6.83% | +0.56% | +8.02% | +3.99% | +3.08% | +13.34% | +11.84% | +16.65% | +14.59% | — |
Risk (36 months)
| Volatility | 14.10% |
| Sharpe | 1.21 |
| Sortino | 2.10 |
| Beta | 0.86 |
| Alpha | +4.17% |
| Deepest fall | -63.37% |
| 1-year periods with a loss | 33% |
| 5Y SIP XIRR | +22.83% |
Top holdings (31 Oct 2026)
| Sun Pharmaceutical Industries Ltd. | 10.55% |
| Divi's Laboratories Ltd. | 8.38% |
| Max Healthcare Institute Ltd. | 4.96% |
| Acutaas Chemicals Ltd. | 4.95% |
| Apollo Hospitals Enterprise Ltd. | 4.87% |
| Laurus Labs Ltd. | 4.76% |
| Cipla Ltd. | 4.36% |
| TREPS | 4.14% |
| Torrent Pharmaceuticals Ltd. | 4.11% |
| Aurobindo Pharma Ltd. | 3.10% |
| Gland Pharma Ltd. | 3.06% |
| Aster DM Quality Care Ltd. | 3.03% |
Sectors
| Pharmaceuticals & Biotechnology | 61.8% |
| Healthcare Services | 29.4% |
| Chemicals & Petrochemicals | 4.4% |
| Healthcare Equipment & Supplies | 1.5% |
Calculated by Growth Analyser from AMFI NAVs and the fund house's disclosed portfolio. Up to 1 year: total return; longer: CAGR. Research and education only; not investment advice. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not indicate future returns.